Enhanced High Penetration Prodrug Compositions for Pulmonary Conditions

This inventive concept relates to improved high penetration prodrug compositions and pharmaceutical formulations for treating pulmonary conditions, enhancing penetration across biological barriers and reducing side effects.

The original patent disclosed high penetration prodrug compositions for treating pulmonary conditions, but had limitations in terms of solubility, delivery, and side effects. The new inventive concept addresses these limitations by introducing novel formulations, carriers, and delivery systems that enhance penetration, solubility, and targeting, while reducing side effects.

The new inventive concept comprises four main aspects: (1) a method of treating pulmonary conditions using high penetration prodrug compositions, (2) a pharmaceutical composition with improved solubility and delivery, (3) a system for delivering the composition with real-time monitoring and dosage adjustment, and (4) a novel manufacturing process. The high penetration prodrug composition is formulated to enhance penetration across biological barriers and reduce side effects associated with the pulmonary condition. The carrier is designed to improve solubility and enhance delivery to the site of action. The system for delivering the composition includes a device for administering the composition and a sensor for monitoring the patient's response to the treatment, with the ability to adjust the dosage based on the patient's response. The manufacturing process involves synthesizing a functional unit, linking it to a transportational unit, and formulating the resulting high penetration prodrug composition into a pharmaceutical dosage form.

The new inventive concept introduces novel formulations, carriers, and delivery systems that enhance penetration, solubility, and targeting, while reducing side effects. The system for delivering the composition with real-time monitoring and dosage adjustment is a significant improvement over the original patent. The manufacturing process is also novel and non-obvious, providing a more efficient and effective way of producing the high penetration prodrug composition.

Alternative embodiments of the inventive concept include using different types of carriers, varying the ratio of functional units to transportational units, and incorporating additional components to enhance targeting and delivery. Variations of the system for delivering the composition could include using different types of sensors or devices for administering the composition.

The enhanced high penetration prodrug compositions and pharmaceutical formulations have significant commercial potential in the treatment of pulmonary conditions, including asthma, lower and upper respiratory tract infections. The target market includes pharmaceutical companies, hospitals, and clinics, with potential revenue streams from licensing, manufacturing, and sales.